Alzheimer’s might be powered by a broken sleep-wake cycle-Click HereBreakthrough blood test finally confirms Chronic Fatigue Syndrome-Click HereGum disease may quietly damage the brain, scientists warn-Click HereScientists reverse Alzheimer’s in mice with groundbreaking nanotech-Click HereIt sounds creepy, but these scientific breakthroughs could save lives-Click HereYour pumpkin might be hiding a toxic secret-Click HereA revolutionary DNA search engine is speeding up genetic discovery-Click HereWhy women live longer than men, explained by evolution-Click HereBananas could be ruining your smoothie’s health benefits-Click HereThis easy daily habit cuts heart risk by two thirds-Click HereSports concussions increase injury risk-Click HereUncovering a cellular process that leads to inflammation-Click HereNew study links contraceptive pills and depression-Click HereA short snout predisposes dogs to sleep apnea-Click HereBuilding a new vaccine arsenal to eradicate polio-Click HereThe Viking disease can be due to gene variants inherited from Neanderthals-Click HereQatar Omicron-wave study shows slow decline of natural immunity, rapid decline of vaccine immunity-Click HereMore than a quarter of people with asthma still over-using rescue inhalers, putting them at increased risk of severe attacks-Click hereProgress on early detection of Alzheimer’s disease-Click HereDried samples of saliva and fingertip blood are useful in monitoring responses to coronavirus vaccines-Click HereDietary fiber in the gut may help with skin allergies-Click HereResearchers discover mechanism linking mutations in the ‘dark matter’ of the genome to cancer-Click HereDespite dire warnings, monarch butterfly numbers are solid-Click HereImmunotherapy may get a boost-Click HereArtificial intelligence reveals a never-before described 3D structure in rotavirus spike protein-Click HereRecurring brain tumors shaped by genetic evolution and microenvironment-Click HereCompound shows promise for minimizing erratic movements in Parkinson’s patients-Click HereConsuming fruit and vegetables and exercising can make you happier-Click HereCOVID-19 slows birth rate in US, Europe-Click HereLink between ADHD and dementia across generations-Click HerePreventing the long-term effects of traumatic brain injury-Click HereStudy details robust T-cell response to mRNA COVID-19 vaccines — a more durable source of protection-Click HereArtificial color-changing material that mimics chameleon skin can detect seafood freshness-Click HereNeural implant monitors multiple brain areas at once, provides new neuroscience insights-Click HereB cell activating factor possible key to hemophilia immune tolerance-Click HereMasks not enough to stop COVID-19’s spread without distancing, study finds-Click HereAI can detect COVID-19 in the lungs like a virtual physician, new study shows-Click HerePhase 1 human trials suggest breast cancer drug is safe, effective-Click HereRe-engineered enzyme could help reverse damage from spinal cord injury and stroke-Click HereWeight between young adulthood and midlife linked to early mortality-Click HereIncreased fertility for women with Neanderthal gene, study suggests-Click HereCoronavirus testing kits to be developed using RNA imaging technology-Click HereFacial expressions don’t tell the whole story of emotion-Click HereAcid reflux drug is a surprising candidate to curb preterm birth-Click HereTreating Gulf War Illness With FDA-Approved Antiviral Drugs-Click HereHeart patch could limit muscle damage in heart attack aftermath-Click HereA nap a day keeps high blood pressure at bay-Click HereIn small groups, people follow high-performing leaders-Click HereTick tock: Commitment readiness predicts relationship success-Click HereA comprehensive ‘parts list’ of the brain built from its components, the cells-Click HereResearchers confine mature cells to turn them into stem cells-Click HereNew tissue-imaging technology could enable real-time diagnostics, map cancer progression-Click HereEverything big data claims to know about you could be wrong-Click HerePsychedelic drugs promote neural plasticity in rats and flies-Click HereEducation linked to higher risk of short-sightedness-Click HereNew 3D printer can create complex biological tissues-Click HereThe creative brain is wired differently-Click HereWomen survive crises better than men-Click HerePrecise DNA editing made easy: New enzyme to rewrite the genome-Click HereFirst Time-Lapse Footage of Cell Activity During Limb RegenerationStudy Suggests Approach to Waking Patients After Surgery

CMV: Hearing Loss in Babies

0

ORLANDO, Fla. (Ivanhoe Newswire) — In the United States, nearly one in three children are already infected with cytomegalovirus or CMV, by age five. The CDC says, over half of adults have been infected with it by age 40. Once it is in a person’s body, it stays there for life and can reactivate. At any time, a person can also be re-infected with a different strain of the virus. Most people with the infection have no symptoms and aren’t aware that they have been infected.

Cytomegalovirus commonly known as CMV, is closely related to the viruses that cause chickenpox and mononucleosis, or mono.

The symptoms of a congenital CMV infection vary. Most babies infected before birth usually show no symptoms after delivery. Those who do may be born prematurely, have a low birth weight, jaundice, or microcephaly, which is a small head.

If not treated properly and in a timely manner, it could lead to premature hearing loss.

Kenneth Alexander, MD, PhD, Chief of the Division of Infectious Diseases, Nemours Children’s Hospital says, “The challenge is, if we wait too long, those hearing pathways don’t develop. If children are not treated, then, doing things like cochlear implants doesn’t work very well. Furthermore, even if it’s not complete hearing loss, these children have significant language delays.”

Florida is one of the latest states, along with Minnesota and New Jersey, to pass legislation that requires testing for congenital CMV.

Doctor Alexander explains, “The bill requires that any baby that fails their newborn hearing screen be tested for cytomegalovirus. If that baby tests positive for cytomegalovirus, it tells us how we have to manage that child.”

Currently, there’s no vaccine to prevent CMV. Washing hands well and often can help reduce the risk of infection. And a mother who has a CMV infection shouldn’t stop breastfeeding her baby.

Experimental vaccines are being tested for women of childbearing age. These vaccines may be useful in preventing CMV infection in mothers and infants and reducing the chance that babies born to women who are infected while pregnant will develop disabilities. Seven states require each newborn that fails the newborn hearing test to be tested for congenital CMV: Connecticut, Florida, Iowa, Kentucky, New York, Utah, and Virginia.

Contributors to this news report include: Adahlia Thomas, Producer; Roque Correa, Editor and Videographer

Sources:

https://www.mayoclinic.org/diseases-conditions/cmv/symptoms-causes/syc-20355358

https://www.cdc.gov/cmv/overview.html

https://kidshealth.org/en/parents/cytomegalovirus.html

https://floridapolitics.com/archives/514930-early-testing-for-virus-causing-infant-hearing-loss-signed-into-law/

https://kidshealth.org/en/parents/cytomegalovirus.html

https://www.mayoclinic.org/diseases-conditions/cmv/symptoms-causes/syc-20355358 /

advocacy@nationalcmv.org)

CRITICAL FACTS ABOUT CMV: HEARING LOSS IN BABIES
REPORT #2978

BACKGROUND: Cytomegalovirus, or CMV, is a common virus that your body retains for life once infected. It rarely causes problems in healthy people, so most people don’t even know they have it. Being pregnant or having a weakened immune system, however, is cause for concern. Women who develop an active CMV infection during pregnancy can pass the virus to their babies, who might then experience symptoms. People with weakened immune systems, especially people who have had an organ, stem cell, or bone marrow transplant, the CMV infection can be fatal. The virus spreads from person to person through body fluids, such as blood, saliva, urine, semen, and breast milk. There are medications that can help treat the symptoms, but there is currently no cure.

(Source: https://www.mayoclinic.org/diseases-conditions/cmv/symptoms-causes/syc-20355358)

CAUSES AND DIAGNOSIS: Over half of the adults in the U.S. have CMV in their body by age 40. A healthy immune system can easily control the virus, but it can make people who have weakened immune systems sick. CMV is not typically caught from casual contact, rather by touching your eyes, nose, or mouth after having contact with an infected person’s saliva, semen, vaginal fluids, blood, urine, or breast milk. CMV spreads easily in places with many young children, like day-care centers, so anyone who spends time there is at higher risk of getting it. There are different types of CMV infection, the first being congenital. This is when a baby gets CMV from its mother before birth. The second type is primary. This is the first time someone gets CMV. It usually doesn’t cause symptoms, but some people may have signs that look like mononucleosis.

The third type is reactivation. An infection that has been dormant can become active again when your immune system is weakened. It can also happen if you have advanced HIV, are in treatment for cancer, or have an organ transplant.

(Source: https://www.webmd.com/hiv-aids/guide/aids-hiv-opportunistic-infections-cytomegalovirus)

ADVANCES IN CMV TREATMENT: The FDA approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients with post-transplant CMV infection/disease that does not respond to available antiviral treatment. Livtencity works by preventing the activity of human cytomegalovirus enzyme pUL97, thus blocking virus replication. “Transplant recipients are at a much greater risk for complications and death when faced with a cytomegalovirus infection,” said John Farley, MD, MPH, director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research. In the study, 352 transplant recipients with CMV infections, who did not respond to treatment, randomly received Livtencity or treatment assigned by a researcher for up to eight weeks. The study compared the two groups’ plasma CMV DNA concentration levels at the end of the eighth week, with efficacy defined as having a level below what is measurable. Of the 235 patients who received the new drug, 56 percent had levels of CMV DNA below what was measurable versus 24 percent of the 117 patients who received an investigator-assigned treatment. The most common side effects included taste disturbance, nausea, diarrhea, vomiting, and fatigue.

(Source: https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-common-type-post-transplant-infection-resistant-other-drugs#:~:text=Today%2C%20the%20U.S.%20Food%20and,with%20or%20without%20genetic%20mutations)

* For More Information, Contact:

 Margot Winick, Public Relations

Margot.Winick@nemours.org

Free weekly e-mail on Medical Breakthroughs from Ivanhoe. To sign up: http://www.ivanhoe.com/ftk